Cost Per Life Saved Of Adjunctive Igm-Enriched Immunoglobulin Treatment Of Sepsis In Germany

  • Nowak A
  • Barlozek M
  • Ruebesam T
  • et al.
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

Objectives: Despite the development of new antibiotics, sepsis continues to lead to death in at least one in four patients. It is also a major cause of child mortality, accounting for 26% of all neonatal deaths worldwide. According to German guidelines, one of the strategies in sepsis management is the adjunctive treatment with IgM-enriched immunoglobulins. This research aims to investigate the cost per life saved of treating sepsis patients with IgM-enriched immunoglobulins. MethOds: A cost per life saved model was developed for Germany. Effectiveness data was obtained from a systematic literature review including only sepsis studies published after 2005 with mortality as a main outcome. The costs were calculated using the list price of IgM-enriched immunoglobulin in Germany and the DRG (Diagnosis Related Groups) revenue for ICU. Results: Based on five studies (N= 502) of adult sepsis patients, treatment with IgM-enriched immunoglobulins reduced the abso-lute mortality rate by 25.5%, rendering a NNT of 3.93. The average treatment costs in Germany are 4106 leading to 16114 costs per life saved. Four studies in pediatric sepsis patients (N= 335) showed an absolute mortality reduction of 32%. For a 2-year-old patient treated with IgM-enriched immunoglobulins, the cost per life saved is 2214. Two studies showed that the ICU length of stay is 2.5 days shorter for pediatric patients treated with IgM-enriched immunoglobulins compared to standard treatment, which yields additional cost savings of 5000 in Germany. cOnclusiOns: The findings suggest that the treatment of septic patients with IgM-enriched immunoglobulins is cost-effective. Therefore IgM-enriched immunoglobulins can be recommended as adjunctive treatment of patients with sepsis.

Cite

CITATION STYLE

APA

Nowak, A., Barlozek, M., Ruebesam, T., & Gockel, U. (2017). Cost Per Life Saved Of Adjunctive Igm-Enriched Immunoglobulin Treatment Of Sepsis In Germany. Value in Health, 20(9), A784. https://doi.org/10.1016/j.jval.2017.08.2285

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free